Lixisenatide Improves Glycemic Control in Asian Type 2 Diabetic Patients Inadequately Controlled With Oral Antidiabetic Drugs: An Individual Patient Data Meta-Analysis.

Shu, Hua; Gu, Li-Na; Men, Li-Chuang; Lu, Ju-Ming

Shu, Hua; Gu, Li-Na; Men, Li-Chuang; Lu, Ju-Ming.

Afiliação

Shu H; Department of Endocrinology, Chinese PLA General Hospital, No. 28 Fuxing Road, Haidian District, Beijing, China.
Gu LN; Sanofi (China) Investment Co., Ltd., 19F Tower III Kerry Center, 1228 Middle Yan'an Road, Shanghai, China.
Men LC; Sanofi (China) Investment Co., Ltd., 19F Tower III Kerry Center, 1228 Middle Yan'an Road, Shanghai, China.
Lu JM; Department of Endocrinology, Chinese PLA General Hospital, No. 28 Fuxing Road, Haidian District, Beijing, China. 13911682036@126.com.

Diabetes Ther ; 7(4): 777-792, 2016 Dec.

Article em En | MEDLINE | ID: mdl-27796905

Palavras-chave

Asia; GLP-1 receptor agonist; Glycemic control; Lixisenatide; Postprandial glucose; Type 2 diabetes mellitus

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Systematic_reviews Idioma: En Revista: Diabetes Ther Ano de publicação: 2016 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google